FdaApplication
ANDA 211674
Identifiers
- fda_app_no: ANDA211674
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-10-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APREMILAST | APREMILAST | 20MG | TABLET;ORAL |
| APREMILAST | APREMILAST | 30MG | TABLET;ORAL |
| APREMILAST | APREMILAST | 10MG | TABLET;ORAL |
3 products